Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Aug;18(4):161-4.
doi: 10.3747/co.v18i4.824.

Triple-negative and basal-like breast cancer: implications for oncologists

J Lachapelle  1 , W D Foulkes
Affiliations

Triple-negative and basal-like breast cancer: implications for oncologists

J Lachapelle et al. Curr Oncol. 2011 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

CONFLICT OF INTEREST DISCLOSURES

WDF has received honoraria from Sanofi–Aventis.

References

    1. Sørlie T, Perou CM, Tibshirani R, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A. 2001;98:10869–7. doi: 10.1073/pnas.191367098. - DOI - PMC - PubMed
    1. Tang P, Skinner KA, Hicks DG. Molecular classification of breast carcinomas by immunohistochemical analysis: are we ready? Diagn Mol Pathol. 2009;18:125–32. doi: 10.1097/PDM.0b013e31818d107b. - DOI - PubMed
    1. Tischkowitz M, Brunet JS, Bégin LR, et al. Use of immunohistochemical markers can refine prognosis in triple negative breast cancer. BMC Cancer. 2007;7:134. doi: 10.1186/1471-2407-7-134. - DOI - PMC - PubMed
    1. Foulkes WD, Smith IE, Reis–Filho JS. Triple-negative breast cancer. N Engl J Med. 2010;363:1938–48. doi: 10.1056/NEJMra1001389. - DOI - PubMed
    1. Rakha E, Reis–Filho JS. Basal-like breast carcinoma: from expression profiling to routine practice. Arch Pathol Lab Med. 2009;133:860–8. - PubMed

LinkOut - more resources